CD8A and neoplasm: This achieves both the immune evasion of the tumour cells as well as creates a more aggressive tumour microenvironment by promoting the production of pro-inflammatory cytokines and causing tumour-infiltrating lymphocyte (TIL) and cytotoxic T-cell (CD8+) exhaustion, which thwarts any attempts of immune targeting by the local T cells [14].